11.48 am | 17 May 2013 |  Source: Reuters

The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November....

10.36 am | 17 May 2013 |  Source: Moneycontrol.com

The Department of Pharmaceuticals on Thursday notified Drug Price Control Order 2013. Once implemented over next few months, prices of 348 essential d...

3.18 pm | 16 May 2013 |  Source: CNBC-TV18

Jagannadham Thununguntla, Strategist & Head of Research at SMC Global Securities Limited is of the view that short term trader can book profits in Cip...

3.03 pm | 16 May 2013 |  Source: CNBC-TV18

According to Parag Doctor, Head - Trading Strategies at Keynote Capital's Ltd, one can book partial profits in Cipla around Rs 450. It has been a lagg...

2.29 pm | 16 May 2013 |  Source: CNBC-TV18

Cipla's acquisition of South Africa's Cipla Medpro will boost Africa business revenue by 2-3 percent, Subhanu Saxena, CEO said on Thursday....

5.31 pm | 15 May 2013 |  Source: Moneycontrol.com

With reference to the earlier announcement dated February 28, 2013, whereby the shareholders of the Company were advised of Cipla's firm intention to ...

4.31 pm | 15 May 2013 |  Source: Reuters

Shares in Cipla Medpro rose 1.9 percent to 9.65 rand by 0948 GMT, below the 10 rand per share offer....

8.25 am | 15 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla reports that shareholders will decide Cipla India’s USD 510-million dollar offer to take over Cipla Medpro on Wednesday...

10.19 am | 13 May 2013 |  Source: CNBC-TV18

Maruti is a play on the yen more than anything, says Sanjeev Prasad of Kotak Institutional Equities. He is bearish on FMCG stocks, and says will not b...

11.05 am | 10 May 2013 |  Source: CNBC-TV18

One can sell Cipla, says Sudarshan Sukhani of s2analytics.com....

8.22 am | 10 May 2013 |  Source: Moneycontrol.com

Stocks in news: NTPC | HMT | Coal India | Indian Hotels | Rolta | Cipla | Gammon Infra | Fortis Healthcare | Tata Motors | Kotak Mahindra Bank | HT Me...

5.54 pm | 30 Apr 2013 |  Source: Moneycontrol.com

Cipla has informed that India Ratings & Research Private Limited, a Fitch Group Company has assigned a IND A1+ rating to the Company’s Rs 1000 crore C...

9.19 am | 29 Apr 2013 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Vishal Kshatriya of Edelweiss, Rakesh Gandhi of FRR Shares and Shardul Kulkarni of Angel Broking, place th...

7.05 pm | 24 Apr 2013 |  Source: PTI

State-run insurance giant LIC has lowered its exposure in 17 blue-chip firms, with sale of shares worth an estimated amount of over Rs 8,800 crore, in...

8.38 am | 23 Apr 2013 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Securities, Vikrant Jadeja, vibranttrades.com and Vishal Malkan, malkansview.com, pl...

10.31 pm | 18 Apr 2013 |  Source: CNBC-TV18

The Indian pharma industry has been fighting off a drugged stupor for a while now but industry growth rates have persistently come in at single-digits...

4.09 pm | 17 Apr 2013 |  Source: PTI

Drug major Cipla today said it has launched biosimilar of Etanercept under the brand name 'Etacept' used for treatment of rheumatic disorders in India...

1.30 pm | 16 Apr 2013 |  Source: Moneycontrol.com

Motilal Oswal has come with its March`13 quarterly earning estimates for healthcare sector. The research firm expects a top line growth of 17.4% YoY a...

10.28 am | 13 Apr 2013 |  Source: Moneycontrol.com

Pharma, banking, leather, personal care and sugar sectors will be getting astrological support says Satish Gupta of Astrostocktips....

6.05 pm | 11 Apr 2013 |  Source: CNBC-TV18

Rajesh Agarwal, Head of Research, Eastern Financiers is of the view that Cipla, ICICI Bank and ITC seems to be a good buy for a longer term horizon....